Neoleish is a vaccination which consists of plasmid DNA containing the LACK gene from Leishmania infantum. It is intended for use in stimulating a protective immune response against Leishmaniasis in dogs from 6 months of age. The onset of this immunity is 58 days and the duration 6 months after the primary vaccination course. The vaccination does not interfere with standard serological testing and so infected and vaccinated dogs can be distinguished.
The product has only just received a positive opinion for initial marketing on the 10th November 2022 so it will be a while before it is released onto the veterinary market. We will provide more information on the product when it becomes available.
If you have any specific questions regarding Neoleish please contact our customer services on [email protected].
Written by: Dr. Nick Garside BVetMed MRCVS
